The Accelerator Network connects BARDA to thirteen accelerators across the U.S. in regions where there is heavy activity in developing health security products and technologies in biotechnology, life science research, and medical innovations. The network supports early-stage companies throughout their journey – from identifying a need to product launch – to help them overcome their biggest business, marketing, and operational hurdles, and achieve success sooner. These partnerships provide BARDA with critical insights and direct connections to our nation’s innovators, through which the development of groundbreaking technology to improve our nation’s health security would not be possible.
If you are interested in working with us, please contant us below
*Figures provided are for a 12 month period 2019-2020
The DRIVe accelerators are an innovation engagement platform that works to support all of BARDA. While the DRIVe accelerators support the programs at DRIVe, they also support the divisions across BARDA with a program called “the BARDA Reverse Pitch”. The BARDA Reverse Pitch is a series of monthly events where a leader from a BARDA division will present an innovation need to our accelerators, who then source market research and introductions to the presenter.
The DRIVe Accelerator Network amplifies BARDA’s marketing and outreach and its ability to reach untapped pools of health security solutions. In addition to the use of social media outreach to reach these untapped solution pools, the DRIVe accelerators host networking and investor pitch style events on behalf of BARDA to increase engagement and access for both BARDA and product developers.
Providing product and business support to the overall health security industry. The DRIVe accelerators leverage their connections with various stakeholders in the healthcare ecosystem to accelerate business and product development. In addition to helping innovators with BARDA relevant technologies to mature their product or business, the DRIVe Accelerator Network provides DRIVe-funded companies with targeted support to help ensure the company’s success. Our accelerator network provides both incubator and accelerator support to our funded companies.
The DRIVe Accelerator Network is uniquely positioned to provide BARDA insights into the innovation landscape for various technologies of interest. The DRIVe accelerators leverage their individual accelerator programming and network to conduct landscape reviews and trends analyses to help BARDA (1) address knowledge gaps within the health security space, (2) uncover market trends and (3) insights into future program areas of interest.
Located on the campus of Stony Brook University, The Center for Biotechnology (CfB) serves as an important catalyst in the development of new biomedical technologies and emerging companies in New York State. Through groundbreaking initiatives, CfB supports the advancement of biomedical innovation by helping to bridge the gap between discovery and commercial success and by training the next generation of biomedical leaders.
First Flight Venture Center (FFVC) is a “high science, high impact” incubator with a proven record of success. FFVC has hosted more than 400 companies and helped launch businesses that have commercialized important new technologies, while creating thousands of jobs in North Carolina. FFVC supports the development of innovative technologies and economic growth by providing early stage businesses with affordable laboratory and office space, management guidance and counseling, as well as shared business and technology support services.
Life Science Washington Institute (LSWI) is a 501(c)(3) non-profit organization that was chartered out of Life Science Washington to help support and develop the entrepreneurial community. LSWI aims to assist life science researchers, entrepreneurs, and companies in bridging the gap between discovery and commercialization through a broad range of activities, including consulting services, regular educational and company showcase events, and the creation of resources pertinent to the issues associated with technology commercialization in Washington state.
The Massachusetts Medical Device Development (M2D2) Center is a highly successful medical device accelerator and incubator. This center combines the engineering and business expertise of University of Massachusetts Lowell with the clinical development expertise of University of Massachusetts Medical School. M2D2 is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources.
The Texas Medical Center (TMC) Innovation Institute focuses on bringing the best solutions to unmet healthcare needs by providing the tools and action plans necessary to move products and companies forward, regardless of their stage of development. It opens access to hospital stakeholders and key opinion leaders across the TMC campus. The Innovation Institute is composed of leading industry partners, including Johnson&Johnson and AT&T Foundry.
The New Orleans BioInnovation Center is a private, not-for-profit life science business incubator comprising three divisions: a 66,000-square-foot wet-lab facility, a professional Commercialization Team, and the New Orleans BioFund, an independent subsidiary, which provides early-stage capital for emerging ventures. The Center works directly with entrepreneurs and researchers to commercialize new technologies spinning out of universities and healthcare institutions, to start and scale globally competitive life science companies.
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health, and diagnostic companies. Their mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. Since 2013, MedTech Innovator has graduated more than 340 startups that have raised $1.8B in follow-on funding and launched 74 products on the market. MedTech Innovator has established partnerships with industry leaders like Johnson & Johnson, RCT Ventures, Olympus and Nipro.
The University City Science Center is a mission-driven nonprofit organization that helps innovators and entrepreneurs across Pennsylvania, New Jersey, and Delaware bring world-changing technologies to market. They provide innovators, entrepreneurs and companies at any stage of the business lifecycle with support and access to resources, programming, capital, and space helping move innovation from idea to IPO, and beyond.
The Purdue Discovery to Innovation Accelerator, located in Discovery Park’s Bindley Bioscience Center, is tasked with launching life sciences discoveries down a commercialization path. In close cooperation with comprehensive technical and business partnerships at Purdue University and numerous industry and academic partners across the state of Indiana, their goal is to ensure that the inventors of cutting-edge technologies with biological/medical applications are supported as they advance from proof of concept to product launch.
Plug and Play Health connects the best startups in the world to healthcare corporations who want to disrupt the industry. Plug and Play Health focuses on digital health technologies that challenge clinical practices, improve data analytics, and enhance the patient journey across the continuum of care. Headquartered in Silicon Valley but with 35 offices all over the globe, they run over 50 accelerator programs a year and partner with over 400 major corporations from every continent.
A non-profit 501(c)(3) organization established in 2004, University Enterprise Laboratories (UEL) has partnered with Gener8tor to provide both incubation and accelerator services not only the Twin Cities’ innovation ecosystem but to the Midwest region at large. The team is shaping and supporting the Midwest’s next generation of life sciences companies, they provide and manage a facility with lab, office space, and supportive programming for early-stage life science, biotech, agriculture, healthcare, materials science, and analytics companies.
The University of Missouri Midwest BioAccelerator (MU-MBar) is focused on boosting biosecurity and biodefense research, leveraging partnerships with industry leaders and searching for solutions to national health security threats. With resources including the USDA and the Midwest Research Institute in Kansas City, Washington University in St. Louis, and the MU Research Reactor, among other research labs in Columbia, Missouri, the work will focus on both human and animal health, creating development opportunities for new technology associated with detecting and mitigating infectious diseases.
Biolocity is a philanthropic, multi-institutional network supporting university medical technology commercialization in the southeast. Through a combination of investment, project management, consulting, and educational programming, Biolocity provides early-stage, patient impacting technologies with the resources needed to reach critical commercialization milestones.